Back to Search Start Over

The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial

Authors :
Bruno Pereira
Romain Valabregue
Nicolas Macian
Gisèle Pickering
Louis Boyer
Claude Dubray
Stéphane Lehéricy
Adrian Kastler
Betty Jean
Centre de Pharmacologie Clinique
Laboratoire de Pharmacologie Médicale
Université d'Auvergne - Clermont-Ferrand I (UdA)
Service d’Imagerie Médicale et Radiologie Interventionnelle [CHU Clermont-Ferrand]
CHU Gabriel Montpied [Clermont-Ferrand]
CHU Clermont-Ferrand-CHU Clermont-Ferrand
Centre d'Investigation Clinique [CHU Clermont-Ferrand] (CIC 1405)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI)
Délégation à la Recherche Clinique et à l'Innovation
CHU Clermont-Ferrand
Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM)
Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Image Science for Interventional Techniques (ISIT)
Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS)
HAL-UPMC, Gestionnaire
Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Source :
Drug Design, Development and Therapy, Drug Design, Development and Therapy, Dove Medical Press, 2015, 9, pp.3853-3862. ⟨10.2147/DDDT.S81004⟩, Drug Design, Development and Therapy, 2015, 9, pp.3853-3862. ⟨10.2147/DDDT.S81004⟩
Publication Year :
2015
Publisher :
HAL CCSD, 2015.

Abstract

Gisèle Pickering,1–3 Adrian Kastler,4 Nicolas Macian,1,2 Bruno Pereira,5 Romain Valabrègue,6 Stéphane Lehericy,6 Louis Boyer,4,7 Claude Dubray,1–3 Betty Jean4 1CHU Clermont-Ferrand, Centre de Pharmacologie Clinique, 2Centre d’Investigation Clinique – Inserm 1405, 3Clermont Université, Laboratoire de Pharmacologie, Faculté de médecine, 4CHU Gabriel Montpied, Clermont-Ferrand, Service d’Imagerie Ostéo-articulaire thoracique et neurologique, 5CHU Clermont-Ferrand, Délégation Recherche Clinique et à l’Innovation, Clermont-Ferrand, France; 6Institut du Cerveau et de la Moelle epiniere – ICM, Centre de NeuroImagerie de Recherche CENIR, Inserm U1127, CNRS UMR 7225, Sorbonne Universités, UPMC University Paris, Paris, France, Department of Neuroradiology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; 7UMR CNRS UdA 6284, Clemont-Ferrand, France Background: Paracetamol’s (APAP) mechanism of action suggests the implication of supraspinal structures but no neuroimaging study has been performed in humans.Methods and results: This randomized, double-blind, crossover, placebo-controlled trial in 17 healthy volunteers (NCT01562704) aimed to evaluate how APAP modulates pain-evoked functional magnetic resonance imaging signals. We used behavioral measures and functional magnetic resonance imaging to investigate the response to experimental thermal stimuli with APAP or placebo administration. Region-of-interest analysis revealed that activity in response to noxious stimulation diminished with APAP compared to placebo in prefrontal cortices, insula, thalami, anterior cingulate cortex, and periaqueductal gray matter.Conclusion: These findings suggest an inhibitory effect of APAP on spinothalamic tracts leading to a decreased activation of higher structures, and a top-down influence on descending inhibition. Further binding and connectivity studies are needed to evaluate how APAP modulates pain, especially in the context of repeated administration to patients with pain. Keywords: paracetamol, nociception, fMRI, pharmacology, pain&nbsp

Details

Language :
English
ISSN :
11778881
Database :
OpenAIRE
Journal :
Drug Design, Development and Therapy, Drug Design, Development and Therapy, Dove Medical Press, 2015, 9, pp.3853-3862. ⟨10.2147/DDDT.S81004⟩, Drug Design, Development and Therapy, 2015, 9, pp.3853-3862. ⟨10.2147/DDDT.S81004⟩
Accession number :
edsair.doi.dedup.....2159827a4dbf27d73fd61995906f5279
Full Text :
https://doi.org/10.2147/DDDT.S81004⟩